Millions of People Will Soon Be Blindsided. Will You Be One of Them?

On April 20 at 7 p.m. ET, Louis Navellier and Matt McCall will reveal an event that’s about to rock the stock market and how you could use it to beat the markets by nearly 11X.

Tue, April 20 at 7:00PM ET

Mid-Day Report: Markets Rocked as Q2 Earnings Reports Come in Mixed

Q2 earnings season may have passed the midway point last week, but plenty of important companies reported earnings this morning, mostly with good results. Stock market futures were down ahead of the market, and heading into afternoon trading the pattern continued, with all markets down.

Let’s check some of the earnings results thus far.

But first, we’ve got the June read on Personal Income and Spending. Income on the headline came in at 0.2%, a touch lower than expectations but true very same as the unrevised May read of 0.2%. Spending was stronger at 0.4%, again the same as the unrevised May figure. The expander core read year over year was 1.6%, also in-line with expectations.

There was also a Paychex IHS Small Business Employment report this morning, which put July small business hiring down 0.12% after a stronger June read. Year to date, small business hiring is up 0.3% and up 0.4% year over year. The strongest market was in new home construction, and the strongest regions were in the Southeast and Mid-Atlantic.

Pharmaceutical giant Pfizer Inc (PFE) posted a beat of two cents on its bottom line on revenues that also slightly surpassed expectations. Guidance was kept in-line. Pfizer has now beaten the Zacks consensus estimate for earnings in each of the last 5 quarters, with an average beat of roughly 12%. For more on PFE earnings, click here.

Keeping within the Big Pharma space for a moment, Procter & Gamble Co (PG) also beat earnings estimates of 74 cents per share by 5 cents on its fiscal Q4 report this morning.

Mallinckrodt PLC (MNK) topped estimates on both top and bottom lines, largely on the back of its specialty brands. The mid-cap pharma company also raised guidance in its latest earnings report.

However, CVS Health Corp (CVS) reported a mixed quarter, and the company lowered guidance for fiscal year 2016.

Sodastream International Ltd (SODA) posted a big beat on its bottom line, and shares in the pre-market are up more than 15%. For more on SODA earnings, click here.

Finally, Royal Caribbean Cruises Ltd (RCL) missed analyst expectations on both top and bottom lines. The major cruise line also lowered its earnings per share guidance.

For in-depth consideration of how Q2 earnings season is unfolding, click here for Zacks Director of Research Sheraz Mian’s latest Earnings Preview report.

Mark Vickery
Senior Editor

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

PFIZER INC (PFE): Free Stock Analysis Report

ROYAL CARIBBEAN (RCL): Free Stock Analysis Report

SODASTREAM INTL (SODA): Free Stock Analysis Report

CVS HEALTH CORP (CVS): Free Stock Analysis Report

PROCTER & GAMBL (PG): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

More From InvestorPlace


Article printed from InvestorPlace Media,

©2021 InvestorPlace Media, LLC